首页> 外文OA文献 >Efficacy of a text messaging (SMS) based intervention for adults with hypertension: protocol for the StAR (SMS Text-message Adherence suppoRt trial) randomised controlled trial.
【2h】

Efficacy of a text messaging (SMS) based intervention for adults with hypertension: protocol for the StAR (SMS Text-message Adherence suppoRt trial) randomised controlled trial.

机译:基于文本消息(SMS)的干预对成人高血压患者的疗效:StAR(SMS文本消息坚持支持试验)的协议随机对照试验。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Interventions to support people with hypertension in attending clinics and taking their medication have potential to improve outcomes, but delivery on a wide scale and at low cost is challenging. Some trials evaluating clinical interventions using short message service (SMS) text-messaging systems have shown important outcomes, although evidence is limited. We have developed a novel SMS system integrated with clinical care for use by people with hypertension in a low-resource setting. We aim to test the efficacy of the system in improving blood pressure control and treatment adherence compared to usual care. METHODS/DESIGN: The SMS Text-message Adherence suppoRt trial (StAR) is a pragmatic individually randomised three-arm parallel group trial in adults treated for hypertension at a single primary care centre in Cape Town, South Africa. The intervention is a structured programme of clinic appointment, medication pick-up reminders, medication adherence support and hypertension-related education delivered remotely using an automated system with either informational or interactive SMS text-messages. Usual care is supplemented by infrequent non-hypertension related SMS text-messages. Participants are 1:1:1 individually randomised, to usual care or to one of the two active interventions using minimisation to dynamically adjust for gender, age, baseline systolic blood pressure, years with hypertension, and previous clinic attendance. The primary outcome is the change in mean systolic blood pressure at 12-month follow-up from baseline measured with research staff blinded to trial allocation. Secondary outcomes include the proportion of patients with 80% or more of days medication available, proportion of participants achieving a systolic blood pressure less than 140 mmHg and a diastolic blood pressure less than 90 mmHg, hospital admissions, health status, retention in clinical care, satisfaction with treatment and care, and patient related quality of life. Anonymised demographic data are collected on non-participants. DISCUSSION: The StAR trial uses a novel, low cost system based on widely available mobile phone technology to deliver the SMS-based intervention, manage communication with patients, and measure clinically relevant outcomes. The results will inform implementation and wider use of mobile phone based interventions for health care delivery in a low-resource setting. TRIAL REGISTRATION: NCT02019823.
机译:背景:为高血压患者提供服务的干预措施可能会改善治疗效果,但要大规模,低成本地给药是一项挑战。尽管证据有限,但一些使用短消息服务(SMS)文本消息系统评估临床干预措施的试验已显示出重要的结果。我们已经开发了一种新型的SMS系统,该系统与临床护理相集成,供资源贫乏的高血压患者使用。与常规护理相比,我们旨在测试该系统在改善血压控制和治疗依从性方面的功效。方法/设计:SMS短信依从性支持试验(StAR)是在南非开普敦的一个初级保健中心对接受过高血压治疗的成年人进行的实用,个体,随机,三臂平行小组试验。干预是一个结构化的程序,包括诊所预约,用药提醒,用药依从性支持以及与高血压有关的教育,这些程序是使用带有信息或交互式SMS文本消息的自动化系统远程提供的。通常的护理是由非高血压相关的SMS文本消息所罕见。参与者按1:1的比例随机分配,常规护理或使用最小化以动态调整性别,年龄,基线收缩压,高血压年龄和以前就诊的两种主动干预措施之一。主要结果是随访12个月时平均收缩压相对于基线的变化,研究人员对试验分配不知情。次要结果包括有80%或更多天可用药物的患者比例,收缩压低于140毫米汞柱和舒张压低于90毫米汞柱的参与者比例,住院情况,健康状况,临床护理保留,对治疗和护理的满意度,以及与患者相关的生活质量。匿名的人口统计数据是针对非参与者收集的。讨论:StAR试验使用一种新颖的低成本系统,该系统基于广泛使用的移动电话技术,可提供基于SMS的干预措施,管理与患者的沟通并衡量临床相关结果。结果将为在资源匮乏的环境中实施和广泛使用基于移动电话的干预措施提供卫生保健提供信息。试用注册:NCT02019823。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号